Lincoln Pharmaceuticals reported Q1 FY27 total income of ₹201.55 crore, up 19.02% YoY, while EBITDA increased 32.29% to ₹51.70 crore. Consolidated net profit rose 30.90% to ₹36.23 crore from ₹27.68 crore. The company targets ₹1,000 crore revenue over the next three years and exports to more than 60 countries.